{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:23:55Z","timestamp":1787768635311,"version":"build-2784847793"},"reference-count":66,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>The aim of this study was to establish practical recommendations for the diagnosis and treatment of influenza-associated invasive aspergillosis (IAPA) based on the available evidence and experience acquired in the management of patients with COVID-19-associated pulmonary aspergillosis (CAPA). The CAPA\/IAPA expert group defined 14 areas in which recommendations would be made. To search for evidence, the PICO strategy was used for both CAPA and IAPA in PubMed, using MeSH terms in combination with free text. Based on the results, each expert developed recommendations for two to three areas that they presented to the rest of the group in various meetings in order to reach consensus. As results, the practical recommendations for the management of CAPA\/IAPA patients have been grouped into 12 sections. These recommendations are presented for both entities in the following situations: when to suspect fungal infection; what diagnostic methods are useful to diagnose these two entities; what treatment is recommended; what to do in case of resistance; drug interactions or determination of antifungal levels; how to monitor treatment effectiveness; what action to take in the event of treatment failure; the implications of concomitant corticosteroid administration; indications for the combined use of antifungals; when to withdraw treatment; what to do in case of positive cultures for Aspergillus spp. in a patient with severe viral pneumonia or Aspergillus colonization; and how to position antifungal prophylaxis in these patients. Available evidence to support the practical management of CAPA\/IAPA patients is very scarce. Accumulated experience acquired in the management of CAPA patients can be very useful for the management of IAPA patients. The expert group presents eminently practical recommendations for the management of CAPA\/IAPA patients.<\/jats:p>","DOI":"10.3390\/jof9030312","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T03:06:43Z","timestamp":1677726403000},"page":"312","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Managing the Next Wave of Influenza and\/or SARS-CoV-2 in the ICU\u2014Practical Recommendations from an Expert Group for CAPA\/IAPA Patients"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8545-5383","authenticated-orcid":false,"given":"Jose","family":"Peral","sequence":"first","affiliation":[{"name":"Intensive Care Unit, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, 28007 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0665-557X","authenticated-orcid":false,"given":"\u00c1ngel","family":"Estella","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Medicine Department, University of C\u00e1diz, University Hospital of Jerez, INIBiCA, 11407 Jerez, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Nuvials","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Hospital Universitari Vall d\u2019Hebron, 08035 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8828-5984","authenticated-orcid":false,"given":"Alejandro","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Intensive Care Department URV\/IISPV\/CIBERES, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iratxe","family":"Seijas","sequence":"additional","affiliation":[{"name":"Intensive Care Department, Hospital Universitario de Cruces, 48903 Barakaldo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cruz","family":"Soriano","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine and Intensive Care Unit, Hospital Ram\u00f3n y Cajal, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"Suberviola","sequence":"additional","affiliation":[{"name":"Intensive Care Service, Hospital Universitario Marqu\u00e9s de Valdecilla, 39008 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6593-5486","authenticated-orcid":false,"given":"Rafael","family":"Zaragoza","sequence":"additional","affiliation":[{"name":"Intensive Care Service, Hospital Universitario Dr. Peset. Fundacion Micellium, C\/La Armada Espa\u00f1ola, L\u2019eliana, 46017 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: A retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Reizine, F., Pinceaux, K., Lederlin, M., Autier, B., Guegan, H., Gacouin, A., Luque-Paz, D., Boglione-Kerrien, C., Bacle, A., and Le Dar\u00e9, B. (2021). Influenza- and COVID-19-Associated Pulmonary Aspergillosis: Are the Pictures Different?. J. Fungi, 7.","DOI":"10.21203\/rs.3.rs-331976\/v1"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e1634","DOI":"10.1093\/cid\/ciaa1298","article-title":"A National Strategy to Diagnose Coronavirus Disease 2019\u2014Associated Invasive Fungal Disease in the Intensive Care Unit","volume":"73","author":"White","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e3606","DOI":"10.1093\/cid\/ciaa1065","article-title":"Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study","volume":"73","author":"Bartoletti","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/myc.13096","article-title":"COVID-19 associated pulmonary aspergillosis","volume":"63","author":"Koehler","year":"2020","journal-title":"Mycoses"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","article-title":"COVID-19-associated Pulmonary Aspergillosis","volume":"202","author":"Rijpstra","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: The French multicentre MYCOVID study","volume":"10","author":"Gangneux","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: An expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"ofab510","DOI":"10.1093\/ofid\/ofab510","article-title":"Coronavirus Disease 2019\u2013Associated Invasive Fungal Infection","volume":"8","author":"Baddley","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00134-021-06449-4","article-title":"Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis","volume":"47","author":"Verweij","year":"2021","journal-title":"Intensive Care Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ezeokoli, O.T., Gcilitshana, O., and Pohl, C.H. (2021). Risk Factors for Fungal Co-Infections in Critically Ill COVID-19 Patients, with a Focus on Immunosuppressants. J. Fungi, 7.","DOI":"10.3390\/jof7070545"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","article-title":"Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19","volume":"8","author":"Alanio","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jhin.2021.04.012","article-title":"Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): A systematic review","volume":"113","author":"Chong","year":"2021","journal-title":"J. Hosp. Infect."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00134-012-2673-2","article-title":"Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: A retrospective study","volume":"38","author":"Wauters","year":"2012","journal-title":"Intensive Care Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1164\/rccm.201612-2540LE","article-title":"Influenza-associated Aspergillosis in Critically Ill Patients","volume":"196","author":"Kolwijck","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S2213-2600(21)00138-7","article-title":"COVID-19-associated Aspergillus tracheobronchitis: The interplay between viral tropism, host defence, and fungal invasion","volume":"9","author":"Vos","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e01006-20","DOI":"10.1128\/JCM.01006-20","article-title":"An Evaluation of the Performance of the IMMY Aspergillus Galactomannan Enzyme-Linked Immunosorbent Assay When Testing Serum To Aid in the Diagnosis of Invasive Aspergillosis","volume":"58","author":"White","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: The 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmi.2021.08.014","article-title":"Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients\u2014A multinational observational study by the European Confederation of Medical Mycology","volume":"28","author":"Prattes","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3201\/eid2711.211174","article-title":"Multinational Observational Cohort Study of COVID-19\u2013Associated Pulmonary Aspergillosis1","volume":"27","author":"Janssen","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"649675","DOI":"10.3389\/fmed.2021.649675","article-title":"Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections among Mechanically Ventilated COVID-19 Patients","volume":"8","author":"Ghazanfari","year":"2021","journal-title":"Front. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/myc.13342","article-title":"Proven COVID-19\u2014Associated pulmonary aspergillosis in patients with severe respiratory failure","volume":"64","author":"Fortarezza","year":"2021","journal-title":"Mycoses"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.cmi.2019.04.031","article-title":"Intensive care management of influenza-associated pulmonary aspergillosis","volume":"25","author":"Koehler","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Feys, S., Almyroudi, M.P., Braspenning, R., Lagrou, K., Spriet, I., Dimopoulos, G., and Wauters, J. (2021). A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA). J. Fungi, 7.","DOI":"10.3390\/jof7121067"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"666296","DOI":"10.3389\/fphar.2021.666296","article-title":"Interactive Effects of Glucocorticoids and Cytochrome P450 Polymorphisms on the Plasma Trough Concentrations of Voriconazole","volume":"12","author":"Jia","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJMra2027424","article-title":"Aspergillus Infections","volume":"385","author":"Thompson","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus","volume":"21","author":"Arendrup","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/imj.15591","article-title":"Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021","volume":"51","author":"Douglas","year":"2021","journal-title":"Intern. Med. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/myc.13254","article-title":"COVID-19-Associated pulmonary aspergillosis: A prospective single-center dual case series","volume":"64","author":"Meijer","year":"2021","journal-title":"Mycoses"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mmcr.2020.06.006","article-title":"Recovery of a triazole-resistant Aspergillus fumigatus in respiratory specimen of COVID-19 patient in ICU\u2014A case report","volume":"31","author":"Saade","year":"2021","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Meijer, E.F.J., Dofferhoff, A.S.M., Hoiting, O., Buil, J.B., and Meis, J.F. (2020). Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report. J. Fungi, 6.","DOI":"10.3390\/jof6020079"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mmcr.2020.06.005","article-title":"Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination","volume":"31","author":"Mohamed","year":"2021","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/infdis\/jix210","article-title":"Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment","volume":"216","author":"Chowdhary","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2015.08.001","article-title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","volume":"21\u201322","author":"Verweij","year":"2015","journal-title":"Drug Resist. Updat."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/1120009X.2018.1506693","article-title":"Assessment of drug-drug interactions between voriconazole and glucocorticoids","volume":"30","author":"Li","year":"2018","journal-title":"J. Chemother."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Ullah, N., Sepulcri, C., and Mikulska, M. (2022). Isavuconazole for COVID-19-Associated Invasive Mold Infections. J. Fungi, 8.","DOI":"10.3390\/jof8070674"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/myc.13469","article-title":"Isavuconazole therapeutic drug monitoring in critically ill ICU patients: A monocentric retrospective analysis","volume":"65","author":"Bertram","year":"2022","journal-title":"Mycoses"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/myc.12960","article-title":"Defining breakthrough invasive fungal infection\u2013Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology","volume":"62","author":"Cornely","year":"2019","journal-title":"Mycoses"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.22738","article-title":"Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications","volume":"110","author":"Miceli","year":"2007","journal-title":"Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1086\/324620","article-title":"Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis","volume":"34","author":"Denning","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/374557","article-title":"Voriconazole Treatment for Less-Common, Emerging, or Refractory Fungal Infections","volume":"36","author":"Perfect","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/myc.12911","article-title":"Posaconazole salvage therapy: The Posifi study","volume":"62","author":"Fortun","year":"2019","journal-title":"Mycoses"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijid.2014.07.007","article-title":"Salvage combination antifungal therapy for acute invasive aspergillosis may improve outcomes: A systematic review and meta-analysis","volume":"28","author":"Panackal","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s10096-020-03923-7","article-title":"Influenza-associated aspergillosis in critically-ill patients\u2014A retrospective bicentric cohort study","volume":"39","author":"Waldeck","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00134-010-2078-z","article-title":"Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection","volume":"37","author":"Lisboa","year":"2011","journal-title":"Intensive Care Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1007\/s00134-018-5332-4","article-title":"Corticosteroid treatment in critically ill patients with severe influenza pneumonia: A propensity score matching study","volume":"44","author":"Moreno","year":"2018","journal-title":"Intensive Care Med."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Chen, L., Han, X., Li, Y., Zhang, C., and Xing, X. (2020). Invasive pulmonary aspergillosis in immunocompetent patients hospitalised with influenza A-related pneumonia: A multicenter retrospective study. BMC Pulm. Med., 20.","DOI":"10.1186\/s12890-020-01257-w"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.cmi.2015.06.022","article-title":"Corticosteroids for the treatment of human infection with influenza virus: A systematic review and meta-analysis","volume":"21","author":"Yang","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13054-015-0764-5","article-title":"Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis","volume":"19","author":"Zhang","year":"2015","journal-title":"Crit. Care"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1097\/CCM.0000000000004093","article-title":"Corticosteroids as Adjunctive Therapy in the Treatment of Influenza: An Updated Cochrane Systematic Review and Meta-analysis","volume":"48","author":"Lansbury","year":"2020","journal-title":"Crit. Care Med."},{"key":"ref_53","first-page":"Cd014963","article-title":"Systemic corticosteroids for the treatment of COVID-19","volume":"8","author":"Wagner","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"108121","DOI":"10.1016\/j.intimp.2021.108121","article-title":"Effectiveness of corticosteroids to treat severe COVID-19: A systematic review and meta-analysis of prospective studies","volume":"100","author":"Li","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s15010-021-01701-x","article-title":"Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): A systematic review and meta-analysis","volume":"50","author":"Chong","year":"2022","journal-title":"Infection"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"102107","DOI":"10.1016\/j.pupt.2021.102107","article-title":"Effects of corticosteroids on COVID-19 patients: A systematic review and meta-analysis on clinical outcomes","volume":"72","author":"Pourafkari","year":"2022","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13613-021-00951-0","article-title":"Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: A multicentre cohort study","volume":"11","author":"Moreno","year":"2021","journal-title":"Ann. Intensive Care"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13054-022-03902-8","article-title":"Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients","volume":"26","author":"Leistner","year":"2022","journal-title":"Crit. Care"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1183\/09031936.00169714","article-title":"Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients","volume":"45","author":"Lee","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jinf.2022.05.015","article-title":"Corticosteroids and superinfections in COVID-19 patients on invasive mechanical ventilation","volume":"85","author":"Olasveengen","year":"2022","journal-title":"J. Infect."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: A randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/cid\/ciab223","article-title":"Coronavirus Disease 2019-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients","volume":"74","author":"Permpalung","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_64","first-page":"790.e791","article-title":"Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: A French multicentric retrospective cohort","volume":"27","author":"Dudoignon","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13054-021-03753-9","article-title":"Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: An observational study","volume":"25","author":"Hatzl","year":"2021","journal-title":"Crit. Care"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00134-021-06431-0","article-title":"Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): A randomised, open-label, proof-of-concept trial","volume":"47","author":"Vanderbeke","year":"2021","journal-title":"Intensive Care Med."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/9\/3\/312\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:45:52Z","timestamp":1760121952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/9\/3\/312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["jof9030312"],"URL":"https:\/\/doi.org\/10.3390\/jof9030312","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,2]]}}}